Author:
Felizardo T C,Wang J C M,McGray R A J,Evelegh C,Spaner D E,Fowler D H,Bramson J L,Medin J A
Publisher
Springer Science and Business Media LLC
Subject
Genetics,Molecular Biology,Molecular Medicine
Reference36 articles.
1. Disis ML, Knutson KL, Schiffman K, Rinn K, McNeel DG . Pre-existent immunity to the HER-2/neu oncogenic protein in patients with HER-2/neu overexpressing breast and ovarian cancer. Breast Cancer Res Treat 2000; 62: 245–252.
2. Fendly BM, Kotts C, Vetterlein D, Lewis GD, Winget M, Carver ME et al. The extracellular domain of HER2/neu is a potential immunogen for active specific immunotherapy of breast cancer. J Biol Response Mod 1990; 9: 449–455.
3. Lu Y, Zi X, Zhao Y, Mascarenhas D, Pollak M . Insulin-like growth factor-I receptor signaling and resistance to trastuzumab (Herceptin). J Natl Cancer Inst 2001; 93: 1852–1857.
4. Mossoba ME, Medin JA . Cancer immunotherapy using virally transduced dendritic cells: animal studies and human clinical trials. Expert Rev Vaccines 2006; 5: 717–732.
5. Loisel-Meyer S, Foley R, Medin JA . Immuno-gene therapy approaches for cancer: from in vitro studies to clinical trials. Front Biosci 2008; 13: 3202–3214.
Cited by
10 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献